Understanding Global Harmonization of Regulatory CMC within Veterinary Medicine with Tammy Newbold

With Lon­za an­tic­i­pat­ing per­sis­tent in­crease in de­mand for com­mer­cial bi­o­log­ics man­u­fac­tur­ing, the Swiss com­pa­ny is pick­ing up a pro­duc­tion site owned by Roche’s Genen­tech for

Wel­come to End­points News’ man­u­fac­tur­ing news briefs, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions, re­calls and more. Charles Riv­er and the Aus­tralian

Share this article The marketing authorisation is applicable for all existing indications approved in the EU for Roche’s Tecentriq IV. Credit: F. Hoffmann-La Roche. Roche